CLINICAL_TRIALS
trial_result
· 2014-12-22
Clinical Trial Update: Pharmacokinetics of BAF312 in Patients With Hepatic Impairment [Phase 1]
Summary
Phase 1 pharmacokinetics study of BAF312 in patients with hepatic impairment completed; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Hepatic Impairment | Phase 1 | Status: COMPLETED | Results posted: 2014-12-22